Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIV
Monday, January 5, 2009 - 15:07
in Health & Medicine
Babies born to HIV-positive mothers and given the antiretroviral drug nevirapine through the first six weeks of life to prevent infection via breast-feeding are at high risk for developing drug-resistant HIV if they get infected anyway, a team of researchers report. But the investigators highlight the proven superiority of the six-week regimen in preventing mother-to-child HIV transmission in breast-fed infants.
Read the whole article on Physorg
More from Physorg
Related
- Prolonged nevirapine in breast-fed babies prevents HIV infection but leads to drug-resistant HIVMon, 5 Jan 2009, 15:09:17 EST
- Combination antiretroviral therapy effective at reducing HIV resistance in mothers and babies following mother-to-child transmissionTue, 27 Oct 2009, 1:56:24 EDT
- ART therapy for babies, mothers safely reduces HIV transmissionWed, 22 Jul 2009, 15:43:13 EDT
- Stanford study finds HIV drug can persist in mothers' milk, increasing risk to them and their babiesTue, 5 Aug 2008, 14:42:46 EDT
- Breast cancer drug shows promise against serious infectionsMon, 20 Jul 2009, 12:15:19 EDT